Skip to content

To study effect of therapy on tumour response

To evaluate the overall therapeutic benefit in terms of tumour response, quality of life and adherence to anticancer therapy in real world cancer patients taking Rasayana therapy along with conventional anticancer therapies.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025307
Enrollment
40
Registered
2020-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Ayurvedic Rasayana Therapy along with conventional chemotherapy: Ayurvedic Rasayana therapy- Personalized Proprietary Herbo-mineral preparations containing 1. Pinzar Rasayan (main ingr

Sponsors

Rasayu Cancer Clinic Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Biopsy or Histopathologically confirmed any stage Cancer 2 Have taken more than 6 months of Rasayana therapy and Completed chemotherapy treatment simultaneously

Exclusion criteria

Exclusion criteria: 1. Diagnosed cases of carcinoma of stage I and II 2. Those patients who are not ready for the study. 3. Patients taking Radiotherapy. 4. Patients have taken less than 6 months of Rasayana Therapy 5. Patients with an expected survival of less than 3 months

Design outcomes

Primary

MeasureTime frame
To evaluate the incidence of tumor response in cancer patients receiving Ayurveda Rasayana therapy along with chemotherapy Timepoint: 6 to 12 months

Secondary

MeasureTime frame
1 To assess QOL of patients Receiving Ayurveda Rasayana therapy along with chemotherapy 2 To assess incidence of adverse drug reactions using CTCAE V 5 criteria of chemotherapy along with Rasayana therapy 3 To assess safety and tolerability to both treatment simultaneously 4 Real world evidence to see its antagonistic/synergistic effect 5 To establish scientific based clarity to patients Timepoint: 6 to 12 months

Countries

India

Contacts

Public ContactDr Yogesh Bendale

Rasayu Cancer Clinic

dr.bendale@gmail.com02024537149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026